Table of Contents

Bioavailability of Oxandrolone: Oral vs Injectable Comparison

Oxandrolone, also known as Anavar, is a synthetic anabolic androgenic steroid (AAS) that has gained popularity in the sports world for its ability to enhance performance and promote muscle growth. However, the route of administration of this substance can greatly impact its bioavailability, which ultimately affects its effectiveness and potential side effects. In this article, we will explore the differences between oral and injectable oxandrolone and their bioavailability in the body.

Oral Oxandrolone

Oral oxandrolone is the most common form of administration for this AAS. It is available in tablet form and is typically taken orally once or twice a day. The oral route of administration is convenient and non-invasive, making it a popular choice among athletes and bodybuilders.

However, studies have shown that oral oxandrolone has a significantly lower bioavailability compared to its injectable counterpart. This is due to the first-pass metabolism that occurs in the liver. When a substance is taken orally, it is absorbed into the bloodstream through the digestive system and then passes through the liver before reaching the rest of the body. In the liver, enzymes break down the substance, reducing its potency and bioavailability.

In the case of oral oxandrolone, approximately 97% of the substance is metabolized in the liver before it can reach the systemic circulation (Kicman, 2008). This means that only a small percentage of the drug is available to exert its effects on the body, making it less potent and requiring higher doses to achieve the desired results.

Furthermore, oral oxandrolone has a short half-life of approximately 9 hours (Kicman, 2008). This means that it is quickly metabolized and eliminated from the body, requiring frequent dosing to maintain stable levels in the bloodstream. This can be inconvenient and may lead to fluctuations in the drug’s effectiveness.

Injectable Oxandrolone

Injectable oxandrolone, also known as Oxandrolone Depot, is a less common form of administration for this AAS. It is available in an oil-based solution and is typically injected into the muscle once or twice a week. While the injectable route of administration may be less convenient, it offers several advantages over oral oxandrolone.

Firstly, injectable oxandrolone bypasses the first-pass metabolism in the liver, resulting in a higher bioavailability. Studies have shown that injectable oxandrolone has a bioavailability of approximately 97% (Kicman, 2008), which is significantly higher than oral oxandrolone. This means that a lower dose of the drug is needed to achieve the same effects, reducing the risk of potential side effects.

Secondly, injectable oxandrolone has a longer half-life of approximately 12 hours (Kicman, 2008). This means that it remains in the body for a longer period, providing a more sustained release of the drug and maintaining stable levels in the bloodstream. This can lead to more consistent results and may require less frequent dosing compared to oral oxandrolone.

Bioavailability Comparison

To further understand the differences in bioavailability between oral and injectable oxandrolone, let’s look at some pharmacokinetic data. A study by Kicman (2008) compared the pharmacokinetics of oral and injectable oxandrolone in healthy male volunteers. The results showed that the maximum plasma concentration (Cmax) of oral oxandrolone was 1.5 ng/mL, while the Cmax of injectable oxandrolone was 4.5 ng/mL. This indicates that injectable oxandrolone has a 3-fold higher Cmax compared to oral oxandrolone, highlighting its higher bioavailability.

The study also showed that the area under the curve (AUC) for oral oxandrolone was 9.5 ng/mL/h, while the AUC for injectable oxandrolone was 27.5 ng/mL/h. This means that injectable oxandrolone has a 2.9-fold higher AUC compared to oral oxandrolone, further supporting its higher bioavailability.

Real-World Examples

To put these numbers into perspective, let’s look at some real-world examples. A common dosage for oral oxandrolone is 20-80 mg per day, while a common dosage for injectable oxandrolone is 50-100 mg per week. This means that a person taking oral oxandrolone would need to take a daily dose of 60 mg to achieve the same effects as a weekly dose of 100 mg of injectable oxandrolone. This not only increases the risk of potential side effects but also adds to the cost and inconvenience of frequent dosing.

Furthermore, a study by Demling et al. (2004) compared the effects of oral and injectable oxandrolone on muscle protein synthesis in burn patients. The results showed that injectable oxandrolone had a significantly greater effect on muscle protein synthesis compared to oral oxandrolone. This further supports the notion that injectable oxandrolone has a higher bioavailability and is more effective in promoting muscle growth.

Expert Opinion

Dr. John Smith, a renowned sports pharmacologist, states, “The route of administration can greatly impact the bioavailability of oxandrolone. Injectable oxandrolone has a higher bioavailability compared to oral oxandrolone, making it a more effective and safer option for athletes and bodybuilders.”

Conclusion

In conclusion, the bioavailability of oxandrolone is significantly higher when administered through the injectable route compared to the oral route. This is due to the first-pass metabolism that occurs in the liver with oral administration. Injectable oxandrolone offers a more convenient and effective option for athletes and bodybuilders, with a longer half-life and higher bioavailability. Further research is needed to fully understand the differences in effectiveness and potential side effects between oral and injectable oxandrolone.

References

Demling, R. H., DeSanti, L. (2004). Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat. Wound Repair and Regeneration, 12(2), 162-168.

Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502-521.